This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2001 Aug 14;57(3):375-6.

doi: 10.1212/wnl.57.3.375.

A cue to queue for CoQ?

C W Shults, A H Schapira

PMID: 11502896
DOI: 10.1212/wnl.57.3.375

Editorial

A cue to queue for CoQ?

C W Shults et al. Neurology. 2001.

. 2001 Aug 14;57(3):375-6.

doi: 10.1212/wnl.57.3.375.

Authors

C W Shults, A H Schapira

PMID: 11502896
DOI: 10.1212/wnl.57.3.375

No abstract available

PubMed Disclaimer

Comment on

A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.
Huntington Study Group. Huntington Study Group. Neurology. 2001 Aug 14;57(3):397-404. doi: 10.1212/wnl.57.3.397. Neurology. 2001. PMID: 11502903 Clinical Trial.
Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency.
Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, Broccolini A, Tonali P, Di Mauro S, Servidei S. Di Giovanni S, et al. Neurology. 2001 Aug 14;57(3):515-8. doi: 10.1212/wnl.57.3.515. Neurology. 2001. PMID: 11502923

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information